Table 4.
Group | n | Before the experiment | At the end of the 12th week | At the end of the 20th week |
---|---|---|---|---|
Blank | 12 | 20.6 ± 1.3 | 23.7 ± 1.5▼ | 25.9 ± 1.8▼▲ |
Model | 12 | 20.1 ± 0.9 | 27.1 ± 1.7▼* | 29.4 ± 0.7▼▲* |
Simvastatin + aspirin | 12 | 20.0 ± 1.2 | 26.6 ± 1.6▼*◇ | 27.4 ± 1.4▼△*◆ |
DSYM low dose | 13/12 | 20.6 ± 1.5 | 27.2 ± 1.4▼*◇ | 27.9 ± 1.3▼△*◆ |
DSYM high dose | 13/12 | 20.3 ± 1.5 | 27.3 ± 1.2▼*◇ | 27.6 ± 1.5▼△*◆ |
(1) Within the group: compared with ‘before the experiment’ ▼ P < .01; compared with ‘at the end of the 12th week’, △ P > .05, ▲ P < .01. (2) Between groups: compared with the blank group * P < .01; compared with the model group, ◇P > .05, ◆ P < .01.